GPT and metabolic dysfunction-associated steatotic liver disease: Treatment with CO could significantly decrease AST levels in HF animals; studies indicate that supplementation with fish oil can decrease both ALT and AST levels in animals with NAFLD [45, 46], and only one study observed the analysis of these enzymes with the capybara oil, in which a positive correlation between treatment and ALT reduction was obtained but did not show significant results concerning AST [22].